- Home
- CLSD vs INCR Comparison
CLSD vs INCR Comparison
Compare CLSD & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLSD
- INCR
- Stock Information
- Founded
- CLSD 2011
- INCR 1994
- Country
- CLSD United States
- INCR Israel
- Employees
- CLSD N/A
- INCR N/A
- Industry
- CLSD Biotechnology: Pharmaceutical Preparations
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- CLSD Health Care
- INCR Health Care
- Exchange
- CLSD Nasdaq
- INCR Nasdaq
- Market Cap
- CLSD 76.6M
- INCR 65.3M
- IPO Year
- CLSD 2016
- INCR N/A
- Fundamental
- Price
- CLSD $1.01
- INCR $1.46
- Analyst Decision
- CLSD Strong Buy
- INCR
- Analyst Count
- CLSD 6
- INCR 0
- Target Price
- CLSD $5.33
- INCR N/A
- AVG Volume (30 Days)
- CLSD 230.0K
- INCR 29.6K
- Earning Date
- CLSD 11-12-2024
- INCR 12-24-2024
- Dividend Yield
- CLSD N/A
- INCR N/A
- EPS Growth
- CLSD N/A
- INCR N/A
- EPS
- CLSD N/A
- INCR N/A
- Revenue
- CLSD $7,703,000.00
- INCR $72,420,918.00
- Revenue This Year
- CLSD N/A
- INCR N/A
- Revenue Next Year
- CLSD $91.87
- INCR $39.30
- P/E Ratio
- CLSD N/A
- INCR N/A
- Revenue Growth
- CLSD 248.39
- INCR N/A
- 52 Week Low
- CLSD $0.92
- INCR $1.17
- 52 Week High
- CLSD $2.12
- INCR $3.72
- Technical
- Relative Strength Index (RSI)
- CLSD 42.14
- INCR 52.10
- Support Level
- CLSD $0.99
- INCR $1.30
- Resistance Level
- CLSD $1.05
- INCR $1.47
- Average True Range (ATR)
- CLSD 0.05
- INCR 0.05
- MACD
- CLSD 0.00
- INCR 0.02
- Stochastic Oscillator
- CLSD 15.38
- INCR 88.83
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.